Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial
By B. Ettinger, D. Black, B. Mitlak, R. Knickerbocker, T. Nickelsen, H. Genant, C. Christiansen, P. Delmas, J. Zanchetta, J. Stakkestad and 7 more. 2000
1,105 citations recorded by the source corpus.
Subfields: Genetics, Oncology, Orthopedics and Sports Medicine
View Paper: https://www.semanticscholar.org/paper/595bc469596aad6effb7724fbd5fd21adf9a0c2e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
- H. Johansson
- Eugene V. McCloskey
- J. Reginster
- Chris Cooper
- R. Rizzoli
- on behalf of the International Osteoporosis Foundation
- Larry Norton
- M. McClung
In Orthopedics and Sports Medicine
- Chris Cooper
- J. Reginster
- Eugene V. McCloskey
- R. Rizzoli
- J. Kanis
- H. Johansson
- on behalf of the International Osteoporosis Foundation
- M. McClung
Citations in the corpus
- Computer-aided diagnosis in medical imaging: Historical review, current status and future potential (2007, background): “[116] Ettinger E, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al.”
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “Raloxifene, 60 mg [161] FN or LS T-score ≤−2.”
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards (2011, neutral): “Ettinger [87] −18”
- Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. (2005, background): “Other antiresorptive agents with proven antifracture efficacy include long-term estrogen therapy (27), raloxifene (28), and nasal calcitonin (29).”
- Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial (2004, methodology): “Complete trial methods have been previously published [4, 7].”